A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

It took years of effort, but one new bill that passed the senate on Thursday will head to Governor Kelly Armstrong’s desk.

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.

Fiji health authorities are scrambling to stem an outbreak of HIV, as growing meth use and alarming needle-sharing trends ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.